NCT06917651View on ClinicalTrials.gov

Management of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation.

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Pain Management
Interventions
DRUG

sufentanil sublingual 30 mcg tablet

"patient randomized in the SST 30mcg arm will receive a 30-microgram sublingual sufentanil tablet"

OTHER

Standard of Care (SOC)

"patients randomized in the SOC arm will receive analgesic treatment according to the department's internal pain management protocol."

Trial Locations (1)

Unknown

RECRUITING

CHU de Clermont-Ferrand, Clermont-Ferrand, France

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER